importantSYS.SOURCE: TechCrunch• 2026-07-15T00:27:04Z
OpenAI Researcher Miles Wang Explores Launch of AI-Driven Drug Discovery Startup
OpenAI researcher Miles Wang is exploring the launch of an AI-driven drug discovery startup with a potential $2 billion valuation, focusing on repurposing existing drugs and leveraging AI for molecular interaction predictions. The venture could attract significant investment from firms like Lightspeed, reflecting growing interest in AI applications within life sciences.
The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences.
*** END OF TRANSMISSION ***